Targeted Radiation Therapy
Neuroendocrine cancers, though rare, can be effectively treated with targeted radiation therapy that minimizes side effects by delivering treatment directly to tumor cells. The lengthy FDA approval process for this innovative therapy highlights the intersection of medical advancements and pharmaceutical profits, revealing how financial incentives can accelerate treatment availability. The discussion also touches on the recent surge in approvals for various treatments, suggesting a pattern linked to market potential.In this clip
From this podcast
Doc Malik
#101 - Turbo Cancers And What You Should Do If You Have Had The mRNA Jabs With Dr William Makis MD
Related Questions